A European Society of Oncologic Imaging (ESOI) survey on the radiological assessment of response to oncologic treatments in clinical practice

ConclusionSince standardized criteria are mainly a prerogative of clinical trials, in daily routine, reporting strategies are left to radiologists and oncologists, which may issue local and diversified recommendations. The survey emphasizes the need for more generally applicable rules for response assessment in clinical practice.Critical relevance statementCompared to clinical trials which use specific criteria to evaluate response to oncological treatments, the free narrative report usually adopted in daily clinical practice may lack clarity and useful information, and therefore, more structured approaches are needed.Key points· Most radiologists consider standardized reporting strategies essential for an objective assessment of tumor response in clinical practice.· Radiologists increasingly rely on RECIST 1.1 in their daily clinical practice.· Treatment response evaluation should require a complete analysis of all imaging time points and not only of the last.Graphical Abstract
Source: Insights into Imaging - Category: Radiology Source Type: research